The intraocular pressure lowering effect of timolol in gel-forming solution

Acta Ophthalmologica Scandinavica

Volumn 74, Issue 2, 1996, Pages 160-162

  Rosenlund, Ellen F ^a,b  

^a Gen Ophthalmological Priv Practice   (Norway)

^b NONE   (Norway)

Author keywords

Gel forming solution; Glaucoma; Pseudoexfoliation; Side effects; Timolol

Indexed keywords

ANTIGLAUCOMA AGENT; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FINLAND; GLAUCOMA; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; VISUAL IMPAIRMENT;

EID: 0029871154     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1996.tb00062.x     Document Type: Article

References (4)

1. Kass M A, Gordon M, Morley R E, Meltzer D W & Goldberg J J (1987): Compliance with topical timolol treatment. AMJO 103: 188-193.
2. Rozier A, Mazuel C, Grove J & Plazonnet B (1989): Gelrite: A novel ion-activated, insitu gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol Int Jourol Pharm 57: 163-168.
3. Saettone M F, Giannaccini B, Chetoni P, Galli G & Chiellini E (1984): Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine. J Pharm Pharm 36: 229-234.
4. Shell J W (1982): Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 26: 207-218.